SYK and tauopathy: Our previous studies showed that the anti-hypertensive dihydropyridine, Nilvadipine, is a Syk inhibitor which can decrease neuroinflammation and amyloid pathology in the PSAPP transgenic mice and tau phosphorylation in the P301S mouse model of tauopathy (Paris et al., 2014).